google-site-verification: googlec7193c3de77668c9.html

Autoimmune disease linked to poor outcomes with myelodysplastic syndrome

[

Autoimmune disease linked to poor outcomes with myelodysplastic syndrome

Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of Clinical Immunology.

Ning Wu, from the Peking University Institute of Hematology and National Clinical Research Center for Hematologic Disease in Beijing, and colleagues retrospectively studied 161 patients with MDS undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) from 2013 to 2024, including 39 patients with preexisting autoimmune disease and 122 matched controls, to understand the combined impact on allo-HSCT.

The researchers found that patients with an autoimmune disease had significantly lower platelet engraftment, a higher relapse rate, inferior leukemia-free survival, and graft-versus-host disease (GVHD)-free, relapse-free survival (GRFS). There were no significant differences observed in overall survival or acute or chronic GVHD. Active autoimmune disease at transplantation conferred higher relapse and worse GRFS in a subgroup analysis.

“Preexisting autoimmune disease is an independent risk factor for poor outcomes, supporting personalized strategies for this high-risk population,” the authors write.

Publication details

Ning Wu et al, The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort study, Clinical Immunology (2026). DOI: 10.1016/j.clim.2026.110710

Journal information:
Clinical Immunology


Clinical categories

Oncology

Who’s behind this story?


Robert Egan

Robert Egan

Bachelor’s in mathematical biology, Master’s in creative writing. Well-traveled with unique perspectives on science and language.

Full profile →

Advertisements

Copyright © 2026 HealthDay. All rights reserved.

Citation:
Autoimmune disease linked to poor outcomes with myelodysplastic syndrome (2026, May 29)
retrieved 29 May 2026
from https://medicalxpress.com/news/2026-05-autoimmune-disease-linked-poor-outcomes.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Source link

Views: 1

See also  Reverse engineering ketamine's effects may lead to new antidepressants

Check Also

Inside Health – Could we eliminate cervical cancer?

Available for over a year Earlier this summer, there was some incredible progress in cervical …

Simple test could help track metabolic health in cancer and chronic disease

[ Researchers writing in Frontiers in Science propose using simple tests to track metabolic health …

Trial finds combined exercise-nutrition intervention safe but not more effective in ICU

[ Credit: Pavel Danilyuk from Pexels A new national clinical trial is helping reshape the …

Leave a Reply

Available for Amazon Prime